Loading data
XRAYNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.68 bn USD | 3.79 bn USD | 3.97 bn USD | 3.92 bn USD | 4.23 bn USD |
| Cost of revenue | 1.84 bn USD | 1.84 bn USD | 1.88 bn USD | 1.8 bn USD | 1.88 bn USD |
| Gross profit | 1.84 bn USD | 1.96 bn USD | 2.09 bn USD | 2.13 bn USD | 2.35 bn USD |
| Research and development expense | 150 m USD | 165 m USD | 184 m USD | 174 m USD | 171 m USD |
| Selling, general and administrative expense | 1.44 bn USD | 1.61 bn USD | 1.61 bn USD | 1.59 bn USD | 1.55 bn USD |
| Operating profit | -422 m USD | -879 m USD | -85 m USD | -937 m USD | 608 m USD |
| Interest expense | — | — | 81 m USD | 65 m USD | 61 m USD |
| Profit before tax | -486 m USD | -936 m USD | -175 m USD | -1.06 bn USD | 545 m USD |
| Income tax expense | 112 m USD | -26 m USD | -43 m USD | -105 m USD | 134 m USD |
| Net income (reported basis) | -598 m USD | -910 m USD | -132 m USD | -950 m USD | 411 m USD |
| Basic earnings per share | -3 USD/share | -4.48 USD/share | -0.62 USD/share | -4.41 USD/share | 1.88 USD/share |
| Diluted earnings per share | -3 USD/share | -4.48 USD/share | -0.62 USD/share | -4.41 USD/share | 1.87 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.